Active Pharmaceutical Ingredients
(API) Production
India’s API bulk drug industry spans Telangana, Andhra Pradesh, and Karnataka, producing over 500 active pharmaceutical ingredients essential for generics, vaccines, and complex therapies. Valued at an $11.8 billion segment of India’s $50 billion pharma sector, it’s growing at a robust ~12–14 % CAGR. State-backed PLI schemes and bulk‑drug parks boost competitiveness, helping India supply more than 35 % of global APIs
Our Clients
Joflo Currently Captures 20% of the Total Indian Pharma Filtration Market. Simultaneous diversification and expansion are directed towards enhanced customer experience
Joflo’s industrial centrifuges play a critical role by efficiently separating solids from liquids, enhancing purity, yield, and compliance with stringent GMP standards—making us a trusted partner in India’s thriving pharmaceutical manufacturing sector
Client Reviews
What Our Clients Say About Us!
Active Engagement in Markets like…
CAMPHOR PRODUCTION INDUSTRY
With some minor modifications, our pharma equipped machines are seen to be a very viable option for camphor production, with one large machine currently being installed in this sector
PETROCHEMICAL INDUSTRY
Our expanding product portfolio has drawn us towards decanters and reactor vessels, equipment that is prime to the petrochemical industry
WASTEWATER TREATMENT INDUSTRY
Our decanter technology, outsourced through technical joint ventures, aims for reduced power consumption during effluent treatment and water extraction from dissolved solid waste
OIL AND GAS, FOOD AND BEVERAGES DEFENCE AND AEROSPACE INDUSTRIES
Joflo envisions expanding product capabilities and portfolios, especially with pressure vessel production capacities